MedTrace Logo

Blind and Ultrasound Guided Injection in Morton Neuroma

NCT03046108 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-10-18

No results posted yet for this study

Summary

The aim of this work trial is to compare the effectiveness of blind and ultrasound guided injection for Morton neuroma in order to determine which is more appropriate as the initial procedure in conservative treatment

Conditions

  • Morton Neuroma

Interventions

DEVICE

blind injection of Morton neuroma

Introduction of a needle based in anatomical landmark

DRUG

blind injection of Mepivacaine

blind injection of 1 cc of Mepivacaine Normon 2% ®

DRUG

blind injection of Triamcinolone

blind injection of 40 mg of triamcinolone (trigon depot ®)

DEVICE

ultrasound guided injection

Introduction of a needle based guided by ultrasound

DRUG

guided injection of mepivacaine

ultrasound guided injection of 1 cc of Mepivacaine Normon 2% ®

DRUG

guided injection of Triamcinolone

ultrasound guided injection of 40 mg of triamcinolone (trigon depot ®)

Sponsors & Collaborators

  • Complejo Hospitalario Universitario de Granada

    lead OTHER

Principal Investigators

  • FERNANDO RUIZ SANTIAGO, PhD · COMPLEJO HOSPITALARIO UNIVERSITARIO GRANADA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03046108 on ClinicalTrials.gov